AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 27- Open
- $0.89
- 52-wk high
- $6.76
- High
- $0.91
- 52-wk low
- $0.85
- Low
- $0.85
- Prev close
- $0.87
- Mkt cap
- $3.5M
- P/E
- 0.0x
- Volume
- 43.4K
- Fwd P/E
- 0.9x
- Beta
- -0.14
- P/S
- 2.9x
- P/B
- 0.4x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -154.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about REVB filings
Are insiders buying or selling Revelation Biosciences Inc (REVB) stock?
Neither. Revelation Biosciences Inc (REVB) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded REVB recently?
None. No member of Congress disclosed a REVB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this REVB smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
2 funds hold a position.
How top traders are positioned
No tracked top-trader positions in REVB right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 4.8% below what analysts expected.
Earnings per share
-$0.83 expected
Reports Nov 5, 2026, in 39 days
Financials
Is the business strong?
Fairly priced and running thin margins.
- Net margin
- 0.0%
- P/E
- 0.03
- Forward P/E
- 0.89
- Market cap
- $3M
Valuation
- P/S2.88
- P/B0.39
Quality
- Operating margin0.0%
- ROE-154.8%
- ROA-78.7%
Growth
- Beta-0.14
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace